scispace - formally typeset
A

Angelo Branzi

Researcher at University of Bologna

Publications -  350
Citations -  17546

Angelo Branzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 58, co-authored 350 publications receiving 16425 citations.

Papers
More filters
Journal ArticleDOI

Sildenafil citrate therapy for pulmonary arterial hypertension.

TL;DR: Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m, and the incidence of clinical worsening did not differ significantly between the patients treated with s Bildenafils and those treated with placebo.
Journal ArticleDOI

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

TL;DR: Fuvastatin treatment in patients with average cholesterol levels undergoing their first successful PCI significantly reduces the risk of major adverse cardiac events.
Journal ArticleDOI

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology

TL;DR: ‘Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes’ recently published in European Heart Journal 1 rightly dedicates space to the pitfalls that can be encountered when reading presentation ECGs, but there is an important omission.
Journal ArticleDOI

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

TL;DR: A meta-analysis of all randomized controlled trials with drugs published in this condition suggests an improvement of survival in the patients treated with the targeted therapies approved for pulmonary arterial hypertension.